Vicore Pharma, the winner of the SwedenBIO Award 2024 is praised for being at the forefront of addressing unmet medical needs in rare diseases and for securing one of Sweden’s largest biotech raises in 2024. Vicore's CEO, Ahmed Mousa, received the award in a prize ceremony during SwedenBIO Summit at Grand Hôtel in Stockholm on 11th December.
SwedenBIO, together with our partners, has prepared a smargosboard of benefits for Swedish companies attending JP Morgan week in San Fransisco.
Pelago Bioscience, Xbrane Biopharma and Vicore Pharma are the finalists for the SwedenBIO Award 2024.
The international event brings together researchers, entrepreneurs and technologists from around the world to solve some of the most pressing health challenges.
As the largest industry event came to town, SwedenBIO mobilized its network to highlight the growth of Sweden's life science industry and to help its members maximize the three-day bonanza.
SwedenBIO, together with its members and partners, proudly welcomes industry leaders and investors to BIO-Europe in Stockholm.
Welcome to our yearly winter networking event SwedenBIO Summit, which takes place at Grand Hôtel in Stockholm on the 11th of December 2024.
The life science sectors in Sweden and Denmark are experiencing impressive growth, solidifying the position of the Nordic region as a key player in the global industry.
Britta Stensson, Head of Global Industry Network Life Science at Business Sweden, shares her view on Swedish Life Science.
Jeannette Edblad, Director of the Swedish government's Office for Life Science, shares her view on how to strengthen the industry.
How to create sustainable trading on the stock exchange
The life science sector is one of the strongest for listed small companies in Sweden. At the same time, the competition in the sector is fierce and it is necessary to work with the issues that affect share trading. A well-functioning share trading is important for creating growth in small and medium-sized companies.
Offer to you as an incubator company
Life for startup companies was not without challenges before the effects of the corona crisis hit, and the situation is now tough for many smaller companies. Now we want to contribute to building Sweden’s next generation of life science companies strong, for future export revenue and innovation power. Startup companies with up to four employees must be members of SwedenBIO for an annual fee of SEK 1,000.
Brännpunkt Life Science is an interview series in collaboration with DNB Sweden that focuses the magnifying glass on the intersection between innovation, capital and health. In the first part, we meet Adam Kostyal, European head of listing at Nasdaq, who looks at how the stock market year looked for the sector, talks about the impact of the pandemic and shares his predictions for the future.
